Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
opioid dependence
Biotech
Tris' opioid alternative reduces post-surgery pain in phase 3
Tris Pharma has pointed to a phase 3 win for its pain relief drug as demonstrating the candidate’s potential to help resolve the opioid crisis.
James Waldron
Jan 22, 2025 8:30am
Pain relief without opioids' ill effects? New molecules found
Oct 3, 2022 3:55pm
ATAI, DemeRx pursue 'neurochemical reset' for addiction
Jan 24, 2020 9:00am
Johns Hopkins unveils $17M center for psychedelics research
Sep 6, 2019 2:20pm
Scorpion toxin could inspire non-opioid pain treatments
Aug 23, 2019 8:45am
Could a pufferfish toxin be a safe alternative to opioids?
Jun 12, 2019 9:00am